579 / 671
Opportunity cost in palliation of NSCLC
• Median survival with inoperable NSCLC
PS 2 - 3 or mets:
120 days
Asymptomatic
No treatment; no toxicity; no loss of survival
Symptomatic
1 treatment for equivalent symptom control and
toxicity to longer treatment
BUT…will any patients live longer with 20Gy/39Gy